Evofem Biosciences
EVFM
$0.01675
Share price
17.96%
Change (1 day)
-16.25%
Change (1 year)
Categories
Evofem Biosciences (EVFM) - Net assets
Net assets on the balance sheet as of December 2023 : -$66.51 M
According to Evofem Biosciences
's latest financial reports the company has -$66.51 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Evofem Biosciences - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-71.8 M | -27.89% |
| 2021-12-31 | $-99.58 M | -7492.35% |
| 2020-12-31 | $1.34 M | -91.39% |
| 2019-12-31 | $15.63 M | -166.95% |
| 2018-12-31 | $-23.36 M | -76.57% |
| 2017-12-31 | $-99.68 M | -936.58% |
| 2016-12-31 | $11.91 M | -49.95% |
| 2015-12-31 | $23.8 M | -63.51% |
| 2014-12-31 | $65.24 M | -1183.97% |
| 2013-12-31 | $-6.02 M | -342.74% |
| 2012-12-31 | $2.47 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.38 B | -2,188.74% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $10.67 M | -116.05% | 🇺🇸 USA |